Predictors of mortality in acute pancreatitis complicated with multidrug-resistant Klebsiella pneumoniae infection

被引:11
|
作者
Wu, Di [1 ]
Ding, Junjie [1 ]
Jia, Yan [1 ]
Liu, Huanmiao [2 ]
Xiao, Jie [2 ]
Peng, Jie [1 ]
机构
[1] Cent South Univ, Dept Gastroenterol, Xiangya Hosp, Xiangya Rd, Changsha 410008, Peoples R China
[2] Cent South Univ, Xiangya Hosp 3, Emergency Dept, Changsha, Peoples R China
基金
中国国家自然科学基金;
关键词
Acute pancreatitis; Multidrug-resistant infection; Mortality; Drug-resistance; Predictor; ATLANTA CLASSIFICATION; DRUG-RESISTANCE; SEPTIC SHOCK; RISK-FACTORS; MICROBIOLOGY; DEFINITIONS; GUIDELINES; MANAGEMENT; PATHOGENS; CRITERIA;
D O I
10.1186/s12879-021-06709-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Multidrug-resistant (MDR) Klebsiella pneumoniae infections, from pancreatic infections to bloodstream infections, influence the mortality of patients with acute pancreatitis (AP) on the condition of limited antibiotic choices. The aim of this study was to investigate the predictor of mortality among AP patients complicated with MDR-K. pneumoniae infections. Methods Seventy-one AP patients who occurred MDR-K. pneumoniae infections from August 1st, 2016 to August 1st, 2020 were enrolled. MDR-K. pneumoniae was defined as the K. pneumoniae strain non-susceptible to at least one agent in three or more antimicrobial categories. MDR-K. pneumoniae isolates were confirmed by Vitek-2 system. Antibiotic susceptibility test was carried out using a micro broth dilution method. Clinical characteristics and drug-resistance rates were retrospectively reviewed, and the predictors of mortality were evaluated by univariate and multivariate analyses. Results The mortality rate of AP patients complicated with MDR-K. pneumoniae infections reached 46.5% (33 of 71), and pancreas (n = 53) was the most common site of MDR-K pneumoniae strains. The drug resistance rates of MDR-K. pneumoniae were high to 11 of 12 common antibiotics (more than 50.0%) except of tigecycline (23.9%). The predictor independently associated with mortality was septic shock (hazard ratio 2.959, 95% confidence intervals 1.396 - 6.272, P = 0.005). Conclusions More attention should be paid for pancreatic MDR-K. pneumoniae infections among AP patients The predictor for mortality of AP patients complicated with MDR-K. pneumoniae infection is septic shock. Therefore, further clinical investigations should focus on areas against septic shock.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Dissemination of clonally related multidrug-resistant Klebsiella pneumoniae in Ireland
    Morris, D.
    O'Connor, M.
    Izdebski, R.
    Corcoran, M.
    Ludden, C. E.
    Mcgrath, E.
    Buckley, V.
    Cryan, B.
    Gniadkowski, M.
    Cormican, M.
    [J]. EPIDEMIOLOGY AND INFECTION, 2016, 144 (02): : 443 - 448
  • [32] Molecular characterization of clinical multidrug-resistant Klebsiella pneumoniae isolates
    Xiaoli Cao
    Xuejing Xu
    Zhifeng Zhang
    Han Shen
    Junhao Chen
    Kui Zhang
    [J]. Annals of Clinical Microbiology and Antimicrobials, 13
  • [33] Primary lung abscess due to multidrug-resistant Klebsiella pneumoniae
    Chrystle, Mascarenhas
    Vishak, Acharya
    Sindhu, Kamath
    Jane, Mendonca
    [J]. BMJ CASE REPORTS, 2021, 14 (09)
  • [34] Clinical Characteristics of Acute Pancreatitis Patients with Multidrug-Resistant Bacterial Infection
    Cheng, Guilan
    Wang, Dingxi
    Zhu, Ping
    Lin, Ziqi
    Zhu, Shichao
    Li, Juan
    Li, Linqian
    Zhang, Yipeng
    Li, Guixiang
    [J]. INFECTION AND DRUG RESISTANCE, 2022, 15 : 1439 - 1447
  • [35] Prevalence of Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates in Nepal
    Odari, Ranjeeta
    Dawadi, Prabin
    [J]. JOURNAL OF TROPICAL MEDICINE, 2022, 2022
  • [36] In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
    Poudyal, Anima
    Howden, Benjamin P.
    Bell, Jan M.
    Gao, Wei
    Owen, Roxanne J.
    Turnidge, John D.
    Nation, Roger L.
    Li, Jian
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (06) : 1311 - 1318
  • [37] Molecular typing of clinical multidrug-resistant Klebsiella pneumoniae isolates
    Mehdi Kashefieh
    Habib Zeighami
    Hossein Samadi Kafil
    Pourya Gholizadeh
    Javid Sadeghi
    Mohammad Hossein Soroush Barhaghi
    Hamed Ebrahimzadeh Leylabadlo
    Reza Ghotaslou
    [J]. Molecular Biology Reports, 2024, 51
  • [38] New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae
    Russo, Alessandro
    Fusco, Paolo
    Morrone, Helen Linda
    Trecarichi, Enrico Maria
    Torti, Carlo
    [J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (01) : 41 - 55
  • [39] Case Report: Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae
    Groschel, Matthias I.
    Omansen, Till F.
    de Lange, Wiel
    van der Werf, Tjip S.
    Lokate, Mariette
    Bathoorn, Erik
    Akkerman, Onno W.
    Stienstra, Ymkje
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2016, 94 (03): : 517 - 518
  • [40] Multidrug-resistant Klebsiella pneumoniae acquisition in lung transplant recipients
    Raviv, Yael
    Shitrit, David
    Amital, Anat
    Fox, Benjamin
    Bakal, Ilana
    Tauber, Renana
    Bishara, Jihad
    Kramer, Mordechai R.
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (04) : E388 - E394